MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Chiron Real Estate Stock

Chiron Real Estate Inc.

XRNNYSEMarkt
US$30.34
-3.2% today

Company data

Sector
Real Estate
Industry
REIT - Healthcare Facilities
Country
United States
CEO
Mark O. Decker Jr.
Employees
30
Market cap
$402 M
IPO
29/06/2016

Chiron is a real estate investment trust focused on investing in and actively managing critical healthcare infrastructure. With more than a decade of experience as a public company, it has built a diversified portfolio anchored by strong tenants who deliver essential care in their communities nationwide.

Chiron Real Estate stock: price history

27/01/26-13.2 %16/10/26

1D

-3.2%

1W

-9.7%

1M

-14.8%

6M

-16.4%

YTD

–

1Y

–

2Y

–

5Y

–

10Y

–

Next earnings date

Next earnings date

03/11/2026 (in 17 days)

Volatility around earnings

~73% stronger price swings than usual

Ask the agents about Chiron Real Estate

Analyst assessment of Chiron Real Estate

PRICE TARGET LOW

US$38.00

CONSENSUS

US$41.00

MEDIAN

US$41.50

PRICE TARGET HIGH

US$43.00

0

STRONG BUY

2

BUY

3

HOLD

0

SELL

0

STRONG SELL

5

TOTAL · Hold

As of: 13/07/2026

ANALYST FIRMRATINGACTIONDATE
BMO CapitalMarket Performmaintain13/07/2026
CitizensMarket Outperformmaintain26/05/2026
BMO CapitalMarket Performmaintain18/05/2026
Compass PointBuy → Neutraldowngrade07/05/2026
BairdNeutralmaintain11/11/2025
JMP SecuritiesMarket Perform → Market Outperformupgrade13/10/2025 (older than 12 months)

Chiron Real Estate stock metrics

P/E

7.76

P/B

0.61

EV/EBITDA

6.49

RETURN ON EQUITY

10.1%

NET MARGIN

166.7%

DEBT/EQUITY

0.97

DIVIDEND YIELD

7.1%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

92.4%

FLOAT SHARES

12,233,079

AVG. DAILY VOLUME (30D)

120,350

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Whitlock Matthew Fitzsimmons

OfficerPurchase50036.38Spontaneous17/08/2026

Whitlock Matthew Fitzsimmons

OfficerPurchase50037.21Spontaneous17/08/2026

Fitzgerald Charles

DirectorPurchase14,00035.78Spontaneous13/08/2026

Decker Mark Okey Jr

OfficerPurchase6,87535.92Spontaneous13/08/2026

Roseth Aaron Robert

OfficerPurchase13,50036.73Spontaneous13/08/2026
Page 1 / 5

Dividends & Stock splits

Dividends

EX-DATEPAY DATEAMOUNTYIELD
20/11/202618/12/2026US$0.165.6 %
20/10/202613/11/2026US$0.167.6 %
21/09/202616/10/2026US$0.165.9 %
20/08/202618/09/2026US$0.165.3 %
20/07/202614/08/2026US$0.166.9 %
Page 1 / 8

Stock splits

DATERATIO
22/09/20251:5

Comparable stocks

Frequently asked questions about Chiron Real Estate stock

What does Chiron Real Estate do?

Chiron Real Estate Inc. is a company in the Real Estate sector, REIT - Healthcare Facilities industry, headquartered in United States.

The CEO is Mark O. Decker Jr., the company employs around 30 people.

The IPO was on 29/06/2016; the stock trades on NYSE under the ticker XRN.

What do analysts say about Chiron Real Estate stock?

5 analysts rate the stock, the consensus is Hold (as of 13/07/2026).

The average price target is US$41.00, ranging from US$38.00 to US$43.00, with a median of US$41.50.

This is an external assessment, not a statement by Market Jury.

When does Chiron Real Estate report next?

The next earnings date is 03/11/2026.

Around past earnings, price swings were roughly 73% stronger than usual.

Does Chiron Real Estate pay a dividend?

Yes. The last dividend was US$0.16 per share, ex-date 20/11/2026, paid on 18/12/2026.

The dividend yield is 7.1% (as of 30/06/2026).

Which stocks are comparable to Chiron Real Estate?

Comparable stocks include Welltower, Ventas, Healthpeak Properties, Healthcare Realty Trust, National Healthcare Properties, Prologis, Equinix and American Tower.

How can I get Chiron Real Estate stock analyzed?

Clicking "Analyze stock" lets five strategies assess Chiron Real Estate against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.